81 related articles for article (PubMed ID: 17220348)
21. Polymorphism in genes of growth hormone receptor (GHR) and insulin-like growth factor-1 (IGF1) and its association with both the IGF1 expression in liver and its level in blood in Polish Holstein-Friesian cattle.
Maj A; Snochowski M; Siadkowska E; Rowinska B; Lisowski P; Robakowska-Hyzorek D; Oprzadek J; Grochowska R; Kochman K; Zwierzchowski L
Neuro Endocrinol Lett; 2008 Dec; 29(6):981-9. PubMed ID: 19112400
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
24. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
Severi G; Hayes VM; Padilla EJ; English DR; Southey MC; Sutherland RL; Hopper JL; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):610-2. PubMed ID: 17372260
[TBL] [Abstract][Full Text] [Related]
25. Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.
Johansson M; McKay JD; Wiklund F; Rinaldi S; Verheus M; van Gils CH; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
J Clin Endocrinol Metab; 2007 Dec; 92(12):4820-6. PubMed ID: 17911177
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
27. Association of a CAV-1 haplotype to familial aggressive prostate cancer.
Haeusler J; Hoegel J; Bachmann N; Herkommer K; Paiss T; Vogel W; Maier C
Prostate; 2005 Oct; 65(2):171-7. PubMed ID: 15948133
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
Cheng I; Plummer SJ; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
[TBL] [Abstract][Full Text] [Related]
29. The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study.
Johansson M; Van Guelpen B; Hultdin J; Wiklund F; Adami HO; Bälter K; Grönberg H; Stattin P
Cancer Causes Control; 2007 Dec; 18(10):1169-74. PubMed ID: 17846906
[TBL] [Abstract][Full Text] [Related]
30. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622
[TBL] [Abstract][Full Text] [Related]
31. Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Huang YC; Lee CM; Chen M; Chung MY; Chang YH; Huang WJ; Ho DM; Pan CC; Wu TT; Yang S; Lin MW; Hsieh JT; Chen YM
Clin Cancer Res; 2007 Mar; 13(5):1412-20. PubMed ID: 17332283
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.
Neuhausen SL; Slattery ML; Garner CP; Ding YC; Hoffman M; Brothman AR
Prostate; 2005 Jul; 64(2):168-74. PubMed ID: 15678496
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
34. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
[TBL] [Abstract][Full Text] [Related]
37. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.
Hayes VM; Severi G; Southey MC; Padilla EJ; English DR; Hopper JL; Giles GG; Sutherland RL
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1223-5. PubMed ID: 16775185
[TBL] [Abstract][Full Text] [Related]
38. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
40. PTPRJ haplotypes and colorectal cancer risk.
Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
